Literature DB >> 23644384

The role of different anesthetic techniques in altering the stress response during cardiac surgery in children: a prospective, double-blinded, and randomized study.

Aymen N Naguib1, Joseph D Tobias, Mark W Hall, Mary J Cismowski, Yongjie Miao, N'diris Barry, Thomas Preston, Mark Galantowicz, Timothy M Hoffman.   

Abstract

OBJECTIVES: Our goal was to evaluate the role of three anesthetic techniques in altering the stress response in children undergoing surgery for repair of congenital heart diseases utilizing cardiopulmonary bypass in the setting of fast tracking or early tracheal extubation. Furthermore, we wanted to evaluate the correlation between blunting the stress response and the perioperative clinical outcomes.
DESIGN: Prospective, randomized, double-blinded study.
SETTING: Single center from December 2008 to May of 2011. PATIENTS: Forty-eight subjects (low-dose fentanyl plus placebo, n = 16; high-dose fentanyl plus placebo, n = 17; low-dose fentanyl plus dexmedetomidine, n = 15) were studied between ages 30 days to 3 years old who were scheduled to undergo repair for a ventricular septal defect, atrioventricular septal defect, or Tetralogy of Fallot.
METHODS: Children undergoing surgical repair of congenital heart disease were randomized to receive low-dose fentanyl (10 mcg/kg; low-dose fentanyl), high-dose fentanyl (25mcg/kg; high-dose fentanyl), or low-dose fentanyl plus dexmedetomidine (as a 1 mcg/kg loading dose followed by infusion at 0.5mcg/kg/hr until separation from cardiopulmonary bypass. In addition, patients received a volatile anesthetic agent as needed to maintain hemodynamic stability. Blood samples were tested for metabolic, hormonal and cytokine markers at baseline, after sternotomy, after the start of cardiopulmonary bypass, at the end of the procedure and at 24 hours postoperatively.
MEASUREMENTS AND MAIN RESULTS: Forty-eight subjects (low-dose fentanyl plus placebo, n = 16; high-dose fentanyl plus placebo, n = 17; low-dose fentanyl plus dexmedetomidine, n = 15) were studied. Subjects in the low-dose fentanyl plus placebo group had significantly higher levels of adrenocorticotropic hormone, cortisol, glucose, lactate, and epinephrine during the study period. The lowest levels of stress markers were seen in the high-dose fentanyl plus placebo group both over time (adrenocorticotropic hormone, p= 0.01; glucose, p = 0.007) and at individual time points (cortisol and lactate at the end of surgery, epinephrine poststernotomy; p < 0.05). Subjects in the low-dose fentanyl plus dexmedetomidine group had lower lactate levels at the end of surgery compared with the low-dose fentanyl plus placebo group (p < 0.05). Although there were no statistically significant differences in plasma cytokine levels between the three groups, the low-dose fentanyl plus placebo group had significantly higher interleukin-6:interleukin-10 ratio at 24 hours postoperatively (p < 0.0001). In addition, when compared with the low-dose fentanyl plus placebo group, the low-dose fentanyl plus dexmedetomidine group showed a lower norepinephrine level from baseline at poststernotomy, after the start of cardiopulmonary bypass, and at the end of surgery (p ≤ 0.05). Subjects in the low-dose fentanyl plus placebo group had more postoperative narcotic requirement (p = 0.004), higher prothrombin time (p ≤ 0.03), and more postoperative chest tube output (p < 0.05). Success of fast tracking was not significantly different between groups (low-dose fentanyl plus placebo 75%, high-dose fentanyl plus placebo 82%, low-dose fentanyl plus dexmedetomidine 93%; p = 0.39).
CONCLUSIONS: The use of low-dose fentanyl was associated with the greatest stress response, most coagulopathy, and highest transfusion requirement among our cohorts. Higher dose fentanyl demonstrated more favorable blunting of the stress response. When compared with low-dose fentanyl alone, the addition of dexmedetomidine improved the blunting of the stress response, while achieving better postoperative pain control.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23644384      PMCID: PMC3885862          DOI: 10.1097/PCC.0b013e31828a742c

Source DB:  PubMed          Journal:  Pediatr Crit Care Med        ISSN: 1529-7535            Impact factor:   3.624


  47 in total

1.  Epidural sufentanil during paediatric cardiac surgery: effects on metabolic response and postoperative outcome.

Authors:  T Bichel; J C Rouge; S Schlegel; I Spahr-Schopfer; A Kalangos
Journal:  Paediatr Anaesth       Date:  2000       Impact factor: 2.556

2.  Stress response in infants undergoing cardiac surgery: a randomized study of fentanyl bolus, fentanyl infusion, and fentanyl-midazolam infusion.

Authors:  E M Gruber; P C Laussen; A Casta; A A Zimmerman; D Zurakowski; R Reid; K C Odegard; S Chakravorti; P J Davis; F X McGowan; P R Hickey; D D Hansen
Journal:  Anesth Analg       Date:  2001-04       Impact factor: 5.108

3.  [Prospective study of systemic inflammatory response syndrome after cardiac surgery as a effective indicator].

Authors:  S Hirai; Y Hamanaka; N Mitsui; M Isaka; M Sutoh
Journal:  Kyobu Geka       Date:  2004-06

4.  Very early extubation after open-heart surgery in children does not influence cardiac function.

Authors:  U Meissner; J Scharf; J Dötsch; M Schroth
Journal:  Pediatr Cardiol       Date:  2007-08-04       Impact factor: 1.655

5.  Caudal epidural sufentanil and bupivacaine decreases stress response in paediatric cardiac surgery.

Authors:  Chaitali Sendasgupta; Neeti Makhija; Usha Kiran; Shiv K Choudhary; R Lakshmy; Sambhu N Das
Journal:  Ann Card Anaesth       Date:  2009 Jan-Jun

6.  Randomised trial of fentanyl anaesthesia in preterm babies undergoing surgery: effects on the stress response.

Authors:  K J Anand; W G Sippell; A Aynsley-Green
Journal:  Lancet       Date:  1987-01-10       Impact factor: 79.321

Review 7.  Dexmedetomidine: applications for the pediatric patient with congenital heart disease.

Authors:  Joseph D Tobias; Punkaj Gupta; Aymen Naguib; Andrew R Yates
Journal:  Pediatr Cardiol       Date:  2011-09-10       Impact factor: 1.655

Review 8.  The systemic inflammatory response after cardiac surgery with cardiopulmonary bypass in children.

Authors:  V Brix-Christensen
Journal:  Acta Anaesthesiol Scand       Date:  2001-07       Impact factor: 2.105

9.  [Clinical profile of systemic inflammatory response after pediatric cardiac surgery with cardiopulmonary bypass].

Authors:  Leonardo Cavadas da Costa Soares; Denise Ribas; Regine Spring; Jean Marcelo Ferreira da Silva; Nelson Itiro Miyague
Journal:  Arq Bras Cardiol       Date:  2010-01       Impact factor: 2.000

10.  The effects of normoxic versus hyperoxic cardiopulmonary bypass on oxidative stress and inflammatory response in cyanotic pediatric patients undergoing open cardiac surgery: a randomized controlled trial.

Authors:  Massimo Caputo; Amir Mokhtari; Chris A Rogers; Nayia Panayiotou; Qiang Chen; Mohamed T Ghorbel; Gianni D Angelini; Andrew J Parry
Journal:  J Thorac Cardiovasc Surg       Date:  2009-02-23       Impact factor: 5.209

View more
  18 in total

Review 1.  [Postoperative opioids, endocrine changes,and immunosuppression].

Authors:  S Haroutounian
Journal:  Schmerz       Date:  2018-10       Impact factor: 1.107

2.  The effect of modified ultrafiltration on angiopoietins in pediatric cardiothoracic operations.

Authors:  Sean M Lang; Mansoor A Syed; James Dziura; Edward Rocco; Paul Kirshbom; Vineet Bhandari; John S Giuliano
Journal:  Ann Thorac Surg       Date:  2014-09-23       Impact factor: 4.330

3.  Changes in Anesthetic and Postoperative Sedation-Analgesia Practice Associated With Early Extubation Following Infant Cardiac Surgery: Experience From the Pediatric Heart Network Collaborative Learning Study.

Authors:  Venu Amula; David F Vener; Charles G Pribble; Lori Riegger; Elizabeth C Wilson; Lara S Shekerdemian; Zhining Ou; Angela P Presson; Madolin K Witte; Susan C Nicolson
Journal:  Pediatr Crit Care Med       Date:  2019-10       Impact factor: 3.624

4.  Dexmedetomidine reduces inflammation in traumatic brain injury by regulating the inflammatory responses of macrophages and splenocytes.

Authors:  Mengyao Ding; Ying Chen; Hengfei Luan; Xiaobao Zhang; Zhibin Zhao; Yong Wu
Journal:  Exp Ther Med       Date:  2019-07-18       Impact factor: 2.447

5.  Perioperative Management of a Child with Hypoplastic Left Heart Syndrome of the Jehovah's Witness Faith Presenting for Hybrid Comprehensive Stage II Procedure.

Authors:  Sathappan Karuppiah; Christopher Mckee; Ashley Hodge; Mark Galantowicz; Joseph Tobias; Aymen Naguib
Journal:  J Extra Corpor Technol       Date:  2016-09

Review 6.  Stress Hyperglycemia During Surgery and Anesthesia: Pathogenesis and Clinical Implications.

Authors:  Nadine E Palermo; Roma Y Gianchandani; Marie E McDonnell; Sara M Alexanian
Journal:  Curr Diab Rep       Date:  2016-03       Impact factor: 4.810

7.  Sedative-hypnotic Binding to 11β-hydroxylase.

Authors:  Ervin Pejo; Xiaojuan Zhou; S Shaukat Husain; Douglas E Raines
Journal:  Anesthesiology       Date:  2016-11       Impact factor: 7.892

8.  Utilizing a Collaborative Learning Model to Promote Early Extubation Following Infant Heart Surgery.

Authors:  William T Mahle; Susan C Nicolson; Danielle Hollenbeck-Pringle; Michael G Gaies; Madolin K Witte; Eva K Lee; Michelle Goldsworthy; Paul C Stark; Kristin M Burns; Mark A Scheurer; David S Cooper; Ravi Thiagarajan; V Ben Sivarajan; Steven D Colan; Marcus S Schamberger; Lara S Shekerdemian
Journal:  Pediatr Crit Care Med       Date:  2016-10       Impact factor: 3.624

Review 9.  Minimally invasive paediatric cardiac surgery.

Authors:  Emile Bacha; David Kalfa
Journal:  Nat Rev Cardiol       Date:  2013-11-05       Impact factor: 32.419

10.  Skin-to-Skin Care is Associated with Reduced Stress, Anxiety, and Salivary Cortisol and Improved Attachment for Mothers of Infants With Critical Congenital Heart Disease.

Authors:  Amy J Lisanti; Abigail C Demianczyk; Andrew Costarino; Maria G Vogiatzi; Rebecca Hoffman; Ryan Quinn; Jesse L Chittams; Barbara Medoff-Cooper
Journal:  J Obstet Gynecol Neonatal Nurs       Date:  2020-11-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.